Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug:70:103491.
doi: 10.1016/j.ebiom.2021.103491. Epub 2021 Jul 17.

COVID-19 rapid antigen testing strategies require careful evaluation

Jacqueline Dinnes  1
Affiliations
Comment

COVID-19 rapid antigen testing strategies require careful evaluation

Jacqueline Dinnes. EBioMedicine. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The author declares no conflict of interest.

Comment on

References

    1. Boehme C, Hannay E, Sampath R. SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings. Lancet Global Health. 2021;9(3) e247-e9. - PMC - PubMed
    1. Peeling RW, Olliaro PL, Boeras DI, Fongwen N. Scaling up COVID-19 rapid antigen tests: promises and challenges. Lancet Infect Dis. 2021 - PMC - PubMed
    1. Mina MJ, Peto TE, García-Fiñana M, Semple MG, Buchan IE. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. Lancet. 2021 - PMC - PubMed
    1. Dinnes J, Deeks JJ, Berhane S. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2021;3 Cd013705. - PMC - PubMed
    1. Wagenhäuser I, Knies K, Rauschenberger V. Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR. EBioMedicine. 2021;69 doi: 10.1016/j.ebiom.2021.103455. - DOI - PMC - PubMed

Substances